How many units of regular insulin should be added to 1 liter of plain normal saline (NS) for a 13-year-old patient with diabetic ketoacidosis (DKA)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: January 6, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Insulin Dosing for DKA in a 13-Year-Old: Add 10 Units Regular Insulin to 1 Liter Normal Saline

For a 13-year-old patient with diabetic ketoacidosis, add 10 units of regular insulin to 1 liter of plain normal saline (0.9% NaCl) to create a standard concentration of 0.1 units/mL for continuous intravenous infusion. This concentration allows for precise titration based on the patient's weight and clinical response 1, 2.

Standard Insulin Concentration Preparation

  • The standard concentration is 100 units of regular insulin in 100 mL of normal saline (1 unit/mL), which can be proportionally adjusted to 10 units in 1 liter (0.1 units/mL) 1, 2
  • This dilution allows for accurate dosing when using standard infusion pumps and facilitates weight-based calculations 1

Initial Dosing Protocol for Pediatric DKA

Critical Pre-Insulin Safety Check

  • Do NOT start insulin if serum potassium is <3.3 mEq/L—this is an absolute contraindication that can cause life-threatening cardiac arrhythmias 1
  • Begin aggressive potassium repletion with 20-40 mEq/L added to IV fluids until K+ ≥3.3 mEq/L 1, 2

Insulin Infusion Initiation

  • For pediatric patients, start continuous IV infusion at 0.1 units/kg/hour WITHOUT an initial bolus dose 2
  • Do NOT give a bolus dose in children—this differs from adult protocols and reduces the risk of cerebral edema 2
  • Target glucose decline of 50-75 mg/dL per hour 1, 2

Infusion Rate Adjustments

If Glucose Doesn't Decline Adequately

  • If plasma glucose does not fall by 50 mg/dL in the first hour, verify adequate hydration status 1, 2
  • If hydration is acceptable, double the insulin infusion rate hourly until achieving steady glucose decline of 50-75 mg/dL/hour 1, 2

When Glucose Reaches 250 mg/dL

  • Add dextrose 5% to the IV fluids when serum glucose falls to 250 mg/dL while continuing insulin infusion 3, 2
  • This prevents hypoglycemia while allowing continued insulin therapy to resolve ketoacidosis 3, 2
  • Target glucose maintenance between 150-200 mg/dL until DKA fully resolves 3, 2

Critical Monitoring Parameters

Laboratory Monitoring

  • Check blood glucose every 2-4 hours 1, 2
  • Draw serum electrolytes, glucose, BUN, creatinine, osmolality, and venous pH every 2-4 hours until stable 1, 2
  • Maintain serum potassium between 4-5 mmol/L throughout treatment 1, 2

DKA Resolution Criteria

All of the following must be met before transitioning off IV insulin: 3, 2

  • Glucose <200 mg/dL
  • Serum bicarbonate ≥18 mEq/L
  • Venous pH >7.3
  • Anion gap ≤12 mEq/L

Common Pitfalls to Avoid

Premature Insulin Discontinuation

  • Never stop IV insulin without administering subcutaneous basal insulin 2-4 hours beforehand—this is the most common error leading to DKA recurrence 1, 2
  • Continue IV insulin for 1-2 hours after giving subcutaneous insulin to ensure adequate plasma levels 1, 2

Inadequate Insulin During Resolution Phase

  • Ketonemia takes longer to clear than hyperglycemia—continue insulin infusion until all resolution criteria are met, not just glucose normalization 3, 2
  • Do not reduce insulin rate prematurely when glucose normalizes; instead add dextrose to IV fluids 3, 2

Potassium Management Errors

  • Insulin drives potassium intracellularly, causing potentially dangerous hypokalemia 1, 2
  • Add 20-30 mEq/L potassium (using 2/3 KCl and 1/3 KPO₄) to each liter of IV fluid once renal function is confirmed 1, 2

Special Considerations for Severe or Refractory Cases

  • In rare cases of severe DKA unresponsive to standard dosing (0.1 units/kg/hour), insulin rates may need to be increased to 0.14-0.15 units/kg/hour 4, 5, 6
  • Some patients with severe insulin resistance may require rates up to 4-6 units/hour or higher with appropriate glucose supplementation 6
  • Always investigate underlying causes such as infection, inadequate initial dosing, or interruption of therapy if DKA fails to resolve 3

References

Guideline

Diabetic Ketoacidosis Treatment Guidelines

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Diabetic Ketoacidosis Treatment Guidelines

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Resolving Diabetic Ketoacidosis

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Diabetic ketoacidosis, hyperuricemia and encephalopathy intractable to regular-dose insulin.

Journal of pediatric endocrinology & metabolism : JPEM, 2017

Research

Severe diabetic ketoacidosis: the need for large doses of insulin.

Diabetic medicine : a journal of the British Diabetic Association, 1999

Related Questions

How is the insulin infusion rate adjusted in diabetic ketoacidosis?
How should I write an order for a regular insulin IV infusion (e.g., 100 U in 100 mL normal saline) in an adult ICU patient with severe hyperglycemia (blood glucose ≥250 mg/dL) or diabetic ketoacidosis?
How do I prepare an insulin infusion for a patient with diabetic ketoacidosis, including concentration, dosing rate, and monitoring?
What is the appropriate management and administration of insulin for a 13-year-old patient with diabetic ketoacidosis (DKA) and altered mental status?
What is the proper protocol for preparing an insulin infusion?
Is there a role for Angiotensin Receptor Blockers (ARBs) in the treatment of a patient with labile hypertension, possibly with comorbidities such as heart failure, diabetes, or chronic kidney disease?
What is the management plan for a patient with a bicuspid aortic valve?
What are the considerations and potential adverse effects when prescribing Hydroxychloroquine (HCQ) for a young to middle-aged female patient with Systemic Lupus Erythematosus (SLE), particularly during pregnancy and lactation?
What is the best course of action for a 32-year-old female patient with hyperglycemia (elevated blood sugar), leukocytosis (increased white blood cell count), eosinophilia (increased eosinophils), and thrombocytosis (increased platelet count), who presented with dizziness and headaches, but currently has no symptoms?
Can a puffy area on the lower back be related to an inferior mesenteric venous varix, especially in a patient with a history of venous insufficiency or other vascular conditions?
Can veruca vulgaris (common warts) present with psoriasiform or lichenoid patterns, especially at extremities?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.